Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F.Y.F.L. de Vos
Choosing Chemotherapy in Patients With Advanced Urothelial Cell Cancer Who Are Unfit to Receive Cisplatin-Based Chemotherapy
Therapeutic Advances in Medical Oncology
Oncology
Related publications
Pcn139 - Cost-Effectiveness Analysis of Pembrolizumab for Patients With Locally Advanced or Metastatic Urothelial Cancer Who Are Ineligible for Cisplatin-Containing Chemotherapy in England
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Combination Chemotherapy for Advanced Urothelial Cancer With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-Vac)
Japanese Journal of Urology
Urology
Phase II Study of Docetaxel Alternating With Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
Clinical Significance of miRNA - 106a in Non-Small Cell Lung Cancer Patients Who Received Cisplatin Combined With Gemcitabine Chemotherapy
Cancer Biology and Medicine
Cancer Research
Oncology
Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma
Modern Chemotherapy
CT-guided Percutaneous Irreversible Electroporation for Patients With Locally Advanced Pancreatic Cancer Who Are Unable to Tolerate Periodic Standard Chemotherapy
HPB
Hepatology
Gastroenterology
Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
Patients With Breast Cancer Who Are Treated With Chemotherapy Risk Long-Term Nerve Damage
Cancer
Cancer Research
Oncology
